Randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke


Phase N/A Results

Trial Description


  • Nimodipine (NimotopĀ®)Drug
    Other Names: The treatment group
    Intervention Desc: Calcium channel blocker (L-type calcium channels)

Trial Design

Randomized, placebo-controlled, double-blind clinical trial of 31 patients.

Patient Involvement

Patients were randomized to receive nimodipine (120 mg/day) or placebo for 28 days. Treatment was begun within 48 hours of ischemic stroke.


Type Measure Time Frame Safety Issue
Primary Mathew's scale score at 4 weeks.